Enorama Pharma Announces Extraordinary Shareholder Meeting

PUBT · 1d ago
Enorama Pharma Announces Extraordinary Shareholder Meeting
  • Enorama Pharma will hold an extraordinary general meeting in Malmö on December 4, 2026, to consider continued operations or liquidation.
  • The board recommends continued operations, with equity fully restored to SEK 24.01 million through financing agreements.
  • Shareholders will also vote on introducing 9% annual interest on DS Global's USD 2.5 million loan, effective December 4, 2026.
  • The loan matures December 31, 2027, with repayment through newly issued shares unless repaid early in cash.
  • Liquidation is proposed as an alternative if shareholders reject continued operations, with estimated distributions of SEK 0 per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enorama Pharma AB published the original content used to generate this news brief on November 17, 2026, and is solely responsible for the information contained therein.